Patents by Inventor ViaCyte, Inc.

ViaCyte, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods Useful for Culturing Differentiable Cells
    Publication number: 20130309708
    Abstract: The present invention relates to cell culture methods and compositions that are essentially serum-free and comprise a basal salt nutrient solution and an ErbB3 ligand.
    Type: Application
    Filed: March 12, 2013
    Publication date: November 21, 2013
    Applicant: VIACYTE, INC.
    Inventor: Viacyte, Inc.
  • ENCAPSULATION OF PANCREATIC CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
    Publication number: 20130209425
    Abstract: The present invention relates to methods for encapsulating pancreatic progenitors in a biocompatible semi-permeable encapsulating device. The present invention also relates to production of human insulin in a mammal in response to glucose stimulation.
    Type: Application
    Filed: March 26, 2013
    Publication date: August 15, 2013
    Applicant: VIACYTE, INC.
    Inventor: VIACYTE, INC.
  • CELL COMPOSITIONS DERIVED FROM DEDIFFERENTIATED REPROGRAMMED CELLS
    Publication number: 20130164787
    Abstract: Disclosed herein are cell culture compositions, for example, pancreatic cell culture compositions, derived from dedifferentiated human reprogrammed pluripotent stem cells, such as induced pluripotent stem (iPS) cells, and methods for producing and using such cell culture compositions.
    Type: Application
    Filed: February 6, 2013
    Publication date: June 27, 2013
    Applicant: VIACYTE, INC.
    Inventor: ViaCyte, Inc.
  • METHODS FOR PURIFYING ENDODERM AND PANCREATIC ENDODERM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS
    Publication number: 20130122520
    Abstract: The present disclosure relates to compositions and methods comprising cell surface markers for hES-derived cells, in particular, endoderm lineage cells including pancreatic endoderm-type cells, derived from hES cells.
    Type: Application
    Filed: December 21, 2012
    Publication date: May 16, 2013
    Applicant: VIACYTE, INC.
    Inventor: ViaCyte, Inc.
  • SCALABLE PRIMATE PLURIPOTENT STEM CELL AGGREGATE SUSPENSION CULTURE AND DIFFERENTIATION THEREOF
    Publication number: 20130115695
    Abstract: The present invention relates to methods for production of undifferentiated or differentiated embryonic stem cell aggregate suspension cultures from undifferentiated or differentiated embryonic stem cell single cell suspensions and methods of differentiation thereof.
    Type: Application
    Filed: November 8, 2012
    Publication date: May 9, 2013
    Applicant: VIACYTE, INC.
    Inventor: ViaCyte, Inc.